1. Meaning of Medical Monitoring in Surrogacy

Medical monitoring refers to the continuous clinical supervision of the surrogate mother and fetus from pre-implantation to post-delivery. It ensures:

• Safe implantation of embryo (IVF-based gestational surrogacy)
• Early detection of complications
• Protection against obstetric risks
• Ethical and legal compliance
• Healthy delivery outcomes

In modern practice (especially gestational surrogacy), the surrogate has no genetic link to the child, and thus monitoring focuses on pregnancy safety rather than genetic risks.

2. Stages of Medical Monitoring in Surrogate Pregnancies

(A) Pre-implantation Screening (Before Pregnancy)

This is the most important eligibility stage.

Surrogate evaluation includes:

• Full medical history (obstetric history, chronic diseases)
• Psychological evaluation (mental readiness and stability)
• Infectious disease screening (HIV, Hepatitis B/C, STIs)
• Hormonal and reproductive assessment
• Uterine health check (ultrasound, hysteroscopy if needed)

Intended parents are also assessed:

• Fertility evaluation
• Embryo quality assessment
• Legal eligibility certification (where applicable)

👉 Purpose: Reduce pregnancy risk and ensure suitability.

(B) IVF and Embryo Transfer Stage

Once selected:

• Hormonal preparation (estrogen + progesterone)
• Endometrial lining monitoring via ultrasound
• Embryo transfer under sterile conditions
• Short-term bed rest and observation

👉 Monitoring focus:

• Implantation success
• Hormonal balance
• Early pregnancy confirmation (β-hCG blood tests)

(C) First Trimester Monitoring (0–12 weeks)

This is the most sensitive phase.

Monitoring includes:

• Weekly/bi-weekly ultrasounds
• Fetal heartbeat confirmation
• Screening for ectopic pregnancy
• Thyroid, sugar level monitoring
• Hormone supplementation adjustments

Key risks monitored:

• Miscarriage risk
• Early bleeding
• Hormonal insufficiency

(D) Second Trimester Monitoring (13–28 weeks)

This phase focuses on fetal development.

Routine monitoring:

• Fetal anomaly scan (18–22 weeks)
• Growth scans every 3–4 weeks
• Cervical length assessment (preterm birth risk)
• Blood pressure and diabetes screening (gestational diabetes)
• Nutritional monitoring

(E) Third Trimester Monitoring (29–delivery)

This stage ensures safe delivery planning.

Monitoring includes:

• Weekly fetal heart rate monitoring (NST)
• Doppler studies for placental function
• Amniotic fluid level checks
• Pre-eclampsia monitoring (BP, proteinuria)
• Delivery planning (C-section vs normal delivery)

👉 Many clinics prefer planned C-section in surrogacy cases to avoid emergency risks.

(F) Labour, Delivery & Postpartum Monitoring

After birth:

For surrogate:

• Monitoring for postpartum hemorrhage
• Infection control
• Mental health evaluation (postpartum depression risk)
• Lactation suppression (if required)

For newborn:

• NICU care if needed
• APGAR scoring
• Genetic/medical evaluation

(G) Legal–Medical Oversight

Medical monitoring is tightly linked with legal safeguards:

• All procedures only in registered surrogacy clinics
• Mandatory insurance coverage for surrogate (often up to 16 months postpartum in India) 
• Consent required for abortion decisions
• Court/authority involvement for parentage orders

3. Key Medical Risks That Monitoring Prevents

• Preeclampsia / eclampsia
• Gestational diabetes
• Placenta previa or abruption
• Preterm labor
• Multiple pregnancy complications
• Psychological stress disorders

4. Important Case Laws on Surrogacy & Medical Monitoring

1. Baby Manji Yamada v. Union of India (2008)

Principle: Recognition of legal parentage in surrogacy disputes

• Supreme Court acknowledged complexity of surrogacy contracts.
• Emphasized need for medical and legal safeguards for surrogate-born children.
• Highlighted absence of clear monitoring/legal framework at the time.

2. Jan Balaz v. Anand Municipality (2009)

Principle: Citizenship and birth registration issues in surrogacy

• German couple’s surrogate twins faced citizenship issues.
• Court stressed need for proper medical documentation and monitoring records.
• Led to stronger regulatory discussions in India.

3. National Legal Services Authority v. Union of India (2014)

Principle: Recognition of reproductive autonomy and dignity

• Though primarily about transgender rights, it reinforced:
  • Bodily autonomy
  • Medical consent standards
• Applied in later surrogacy ethics discussions regarding surrogate consent and monitoring.

4. Baby Manji & ART Regulation Cases (ICMR-linked jurisprudence)

Principle: Need for ART regulation

• Courts repeatedly emphasized lack of structured medical oversight in surrogacy.
• Strengthened demand for continuous medical supervision protocols in ART clinics.

5. Shiv Kumar Sharma v. Union of India (Delhi High Court, 2015)

Principle: Regulation of assisted reproduction clinics

• Court highlighted risks of unregulated IVF/surrogacy clinics.
• Emphasized medical monitoring standards, record keeping, and accountability.

6. Surrogacy Regulation Act constitutional challenge cases (post-2021 litigation trends)

Principle: State control over surrogacy for ethical medical monitoring

• Courts upheld government authority to regulate surrogacy clinics.
• Reinforced:
  • Mandatory medical screening
  • Insurance protection
  • Restricted eligibility
• Justified on grounds of protecting surrogate health and preventing exploitation.

5. Conclusion

Medical monitoring in surrogate pregnancies is a multi-layered clinical and legal system that spans:

• Pre-pregnancy screening
• IVF monitoring
• Trimester-wise fetal tracking
• Delivery supervision
• Postpartum care

Judicial decisions across India have consistently reinforced that surrogacy must be medically supervised, ethically regulated, and legally documented, primarily to protect the surrogate’s health and dignity while ensuring safe childbirth outcomes.